Ironwood Pharmaceuticals (IRWD) Earnings Date, Estimates & Call Transcripts → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free IRWD Stock Alerts $7.00 +0.26 (+3.86%) (As of 05/10/2024 08:55 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 9) -$0.02 Missed By -$0.20 Consensus EPS (May. 9) $0.18 Read Call TranscriptListen to Call Get Ironwood Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for IRWD and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIRWD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IRWD Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyObama’s Forever Term [exposed]America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here Ironwood Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$0.14$0.18$0.16 Q2 20242$0.14$0.21$0.18 Q3 20242$0.12$0.15$0.14 Q4 20242$0.10$0.17$0.14 FY 20248$0.50$0.71$0.61 Q1 20251$0.21$0.21$0.21 Q2 20251$0.22$0.22$0.22 Q3 20251$0.21$0.21$0.21 Q4 20251$0.21$0.21$0.21 FY 20254$0.85$0.85 $0.85IRWD Earnings Date and InformationIronwood Pharmaceuticals last announced its quarterly earnings data on May 9th, 2024. The biotechnology company reported ($0.02) earnings per share for the quarter, missing analysts' consensus estimates of $0.18 by $0.20. The firm earned $74.90 million during the quarter, compared to analyst estimates of $105.75 million. Its revenue was down 28.0% on a year-over-year basis. Ironwood Pharmaceuticals has generated ($6.79) earnings per share over the last year (($6.79) diluted earnings per share). Earnings for Ironwood Pharmaceuticals are expected to grow by 28.36% in the coming year, from $0.67 to $0.86 per share. Ironwood Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Ironwood Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024Estimated)------- 5/9/2024Q1 2024$0.18($0.02)($0.20)($0.01)$105.75 million$74.90 million 11/9/2023Q3 2023$0.17$0.12($0.05)$0.15$112.90 million$113.74 million 8/8/2023Q2 2023$0.25$0.31+$0.06$7.46$103.46 million$107.38 million5/4/2023Q1 2023$0.24$0.25+$0.01$0.25$100.60 million$104.06 million 2/16/2023Q4 2022$0.28$0.27($0.01)$0.27$108.23 million$107.20 million 11/3/2022Q3 2022$0.27$0.28+$0.01$0.28$111.51 million$108.64 million Get the Latest News and Ratings for IRWD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ironwood Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022$0.31$0.21($0.10)$0.21$103.51 million$97.23 million 5/5/2022Q1 2022$0.27$0.21($0.06)$0.21$96.62 million$97.53 million 2/17/2022Q4 2021$0.31$0.27($0.04)$0.29$110.18 million$117.13 million 11/4/2021Q3 2021$0.31$0.33+$0.02$0.32$105.27 million$103.75 million 8/5/2021Q2 2021$0.23$0.34+$0.11($1.71)$92.47 million$104.00 million Ironwood Pharmaceuticals Earnings - Frequently Asked Questions When is Ironwood Pharmaceuticals's earnings date? Ironwood Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on IRWD's earnings history. Did Ironwood Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Ironwood Pharmaceuticals (NASDAQ:IRWD) missed the analysts' consensus estimate of $0.18 by $0.20 with a reported earnings per share (EPS) of ($0.02). Learn more on analysts' earnings estimate vs. IRWD's actual earnings. How can I listen to Ironwood Pharmaceuticals's earnings conference call? The conference call for Ironwood Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Ironwood Pharmaceuticals's conference call transcript? The conference call transcript for Ironwood Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Ironwood Pharmaceuticals generate each year? Ironwood Pharmaceuticals (NASDAQ:IRWD) has a recorded annual revenue of $442.73 million. How much profit does Ironwood Pharmaceuticals generate each year? Ironwood Pharmaceuticals (NASDAQ:IRWD) has a recorded net income of -$1.00 billion. IRWD has generated -$6.79 earnings per share over the last four quarters. What is Ironwood Pharmaceuticals's EPS forecast for next year? Ironwood Pharmaceuticals's earnings are expected to grow from $0.67 per share to $0.86 per share in the next year, which is a 28.36% increase. More Earnings Resources from MarketBeat Related Companies: Ligand Pharmaceuticals Earnings Date MannKind Earnings Date Dynavax Technologies Earnings Date Innoviva Earnings Date OPKO Health Earnings Date Zentalis Pharmaceuticals Earnings Date Cryoport Earnings Date IGM Biosciences Earnings Date Lexicon Pharmaceuticals Earnings Date Vanda Pharmaceuticals Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:IRWD) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityElon’s New Device is About to Shock the WorldInvestorPlaceThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon to Transform U.S. Economy? Porter & CompanyBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
